The ultimate objective of nanoparticle-based therapy is to functionalize nanomedicines in a micro-disease environment without any side effects. Here, we reveal that our pH-responsive nitroxide radical-containing nanoparticles (RNP pH ) disintegrate within the renal acidic lesion and act as scavengers of reactive oxygen species (ROS), leading to a relief of acute kidney injury (AKI). RNP pH was prepared using amphiphilic block copolymers possessing 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) moieties via amine linkage as a side chain of the hydrophobic segment. The self-assembled RNP pH disintegrated at pH below 7.0 because of a protonation of the amino groups in the hydrophobic core of the nanoparticles, thereby resulting in an improvement in ROS scavenging activity. Using a renal ischemia-reperfusion AKI model in mice, the therapeutic effect of RNP pH on ROS damage was evaluated. Unlike the RNP without pH-triggered disintegration (RNP Non-pH ), the RNP pH showed extremely high ROS scavenging activity and renal protective effects. It is interesting to note that the side effect of nitroxide radicals was markedly suppressed due to the compartmentalization of nitroxide radicals in the core of RNP pH in untargeted area.
Introduction
Acute kidney injury (AKI) is evoked by multiple disorder and the morbidity and mortality rates of AKI patients have been keeping high level despite significant advances in the management of the disease in recent years [ 1] . One potential mechanism for the irreversible damage is the generation of reactive oxygen species (ROS), which leads to the stimulation of pro-apoptotic mediators, inflammatory cytokines and further oxidative stress [ 2 -4 ] . Redox-targeted therapies using antioxidants have been attracted much attention and widely attempted clinically.
Though they worked to some extent, it remains incomplete [5 To improve the therapeutic efficiencies of drugs, the precise control of pharmacokinetics is crucial. Drug delivery nanoparticles using polymeric micelles or liposomes are able to control the drug pharmacokinetics and some of them have already ]. Since redox reaction is one of the most important events in biological activity, severe and unexpected side effects were caused if antioxidant turns around the body after high-dose administration.
To obtain therapeutic efficiency and suppress unwanted effects, the innovative strategy must be required. If drug, which effectively scavenges ROS excessively generated at specific-lesion, retaining dormant character under untargeted area, it can be safe and effective medication.
been commercialized for anti-cancer therapy [6] [7] [8] . Nanoparticles are known to accumulate in specific regions because of the changes in the specific vascular microenvironment [ 9 ] . More than 90 % of the nanoparticles, however, spread non-specifically in vivo after systemic administration [10, 11] . Active targeting is one of the challenges to improve nanoparticle accumulation in specific disease areas; however, to date, no remarkable effect on its biodistribution has been reported [12] .
When ligands with high specificity are installed on the carrier surface, its blood circulation tendency often decreases due to the lowered colloidal stability [13] . Even if the ligand-installed carrier works well in vitro, it is very difficult to effectively work under in vivo conditions. One promising target to improve the efficiency of nanotherapy is "on-off regulation", whereby the nanoparticle is dormant in non-target tissue and is activated in the target area, thus improving treatment outcomes and decreasing side effects [14 Here, we propose a promising therapy, "Environmental-Signal-Enhanced Polymer Drug Therapy" (ESEPT) for AKI (see Fig. 1 ). The main concepts of ESEPT are: (1) installation of the drug in a hydrophobic segment of an amphiphilic block copolymer via a covalent linkage; (2) self-assembly of the block copolymer to compartmentalize the drugs in the core of the nanoparticle; and (3) disintegration of the nanoparticle in ].
response to a signal, such as pH, in the disease environment. Thus, the ESEPT strategy improves the therapeutic efficiency and suppresses the significant side effects.
The polymer designed for ESEPT in this study is a poly(ethylene glycol)-b-poly(methylstyrene) (PEG-b-PMS) block copolymer, attached to 2,2,6,6-tetramethylpiperidine-N-oxyl (TEMPO) via an amine linkage (PEG-b-PMNT) (see Fig. 1 ) [15] . PEG-b-PMNT forms a core-shell type of self-assembling polymeric micelle in aqueous media, and it disintegrates under acidic conditions due to the protonation of amino groups located in the core of the nitroxide-radical-containing particle (RNP pH ) [16, 17] . Simultaneously, the RNP pH exposes the nitroxide radicals, which can catalytically scavenge ROS [18, 19] . Therefore, we hypothesized that the treatment of AKI is a suitable target of ESEPT by RNP pH . The aim of this study was to demonstrate a rational strategy for ESEPT using a renal ischemia-reperfusion (IR) induced AKI model in mice. If RNP pH can disintegrate and scavenge ROS in response to low pH in renal ischemic regions [ 20 ] , it might become an ideal therapeutic nanoparticle for AKI.
Methods

Preparation of RNP pH
pH-responsive RNP pH was prepared by a self-assembling PEG-b-PMNT block copolymers, as previously reported [15, 16] . Briefly,
MeO-PEG-b-poly(chloromethylstyrene) (PCMS) was synthesized by the radical telomerization of chloromethylstyrene (CMS) using MeO-PEG-SH (Mn = 5,000) as a telogen. To obtain PEG-b-PMNT, the chloromethyl groups on the PCMS segment of the block copolymer were converted to nitroxide radicals via the amination of 
Preparation of RNP Non-pH
Non-pH-responsive RNP Non-pH was prepared by a self-assembling amphiphilic block copolymer (PEG-b-PMOT) composed of the PEG segment and the PMS segment possessing TEMPO moieties as a side chain via ether linkage, as show in Fig. S1 .
Please see Supplementary Methods about detailed preparation method.
Measurement of the scavenging activity of RNP against superoxide
The spin trap method was performed using 5,5-dimethyl-1-pyrroline-N-oxide (DMPO) as a spin-trapping agent to detect superoxide generated by the reaction of 
Animals
Male ICR mice between 9 and 11 weeks old were maintained in the experimental animal facilities at the University of Tsukuba. All experiments were performed according to the Guide for the Care and Use of Laboratory Animals at the University of Tsukuba.
Renal ischemia-reperfusion
Animals were anesthetized initially with pentobarbital sodium (40 mg/kg).
After right heminephrectomy, the left renal pedicle was clamped through flank incisions for 50 min using a microvascular clip to produce ischemia and then reperfusion was 
Assessment of renal function
Blood samples were collected by intracardiac puncture using heparined syringe at 24 h after reperfusion. Then, plasma samples were obtained by centrifugation (6, 200 rpm, 2000 g, 10 min) of the blood. Plasma samples were assayed for BUN and Cr using a Fuji Dri-chem 3500 (Fuji-Film, Tokyo, Japan).
Morphological studies
Please see Supplementary Methods.
Measurement of renal superoxide production
To determine superoxide production, kidneys excised from mice were 
Cytokine measurements
Plasma levels of cytokines were determined at 24 h after reperfusion. IL-6 was measured by a commercial available enzyme-linked immunoassay kit (Thermo Scientific Pierce Protein Research Products) according to manufacturer's instrument.
Measurement of TBARS
The degree of lipid peroxidation in the kidney tissue was determined by measuring the malondialdehyde (MDA) levels with TBARS. Kidney was frozen and stored at -80 ˚C until the assay. Briefly, a 10 % (wt/vol) kidney homogenate was prepared in 0.1 M PB solution containing 1 mM EDTA followed by centrifugation at 600 g for 15 min at 4 ˚C. An aliquot of the supernatant was added to the reaction mixture containing 8 % SDS, 20 % acetic acid, 0.8 % thiobarbituric acid, and water.
After incubation at 95 ˚C for 1 h, the amount of MDA formed in the reaction mixture was measured by a spectrophotometer at an absorbance of 532 nm. MDA was used as the standard, and TBARS values were expressed as nmol per mg protein.
ESR Measurement of concentration of the nitroxide radicals in blood and in kidney.
ICR mice subjected to IR injury were anesthetized via an intraperitoneal injection of pentobarbital sodium (40 mg/kg). 
Effect of RNP on blood pressure
Ten-weeks-old ICR mice were anesthetized with an interperitoneal injection of pentobarbital sodium (40 mg/kg). Blood pressure was measured at 15 min after intravenous administration of PBS, RNP pH , RNP Non-pH , amino-TEMPO or hydroxyl-TEMPO by the indirect tail-cuff method with a blood pressure monitor (model MK-1030, Muromachi Kikai, Tokyo, Japan).
Statistical analysis
All values are expressed as mean ± SE. Continuous data between groups were compared by one-way ANOVA. All ANOVAs were performed with ANOVA tests followed by Tukey's test. Differences with a value of P < 0.05 were considered statistically significant. polydispersity factor, µ/Γ 2 = 0.061) (see Fig. 2a ). Table S1 ). None of drugs caused renal dysfunction or had any other toxicity in normal ICR mice ( Supplementary Information, Fig. S4 Fig. 3a and 3b) . Clearly, the RNP pH outperforms low-molecular-weight TEMPO derivatives in reducing renal dysfunction.
Results
Characterization of RNP
Moreover, therapeutic effect of RNP pH was greater than that of RNP Non-pH (BUN; 34.29, Cr; 0.89), indicating that the disintegration of RNP pH might improve its therapeutic efficiency. To further investigate renal IR injury after treatment, hematoxylin and eosin (HE) staining was conducted. As shown in Fig. 3c and Table 1 , HE staining revealed that tubular cell swelling, interstitial edema, and tubular dilatation were significantly more severe in the vehicle-treated IR mice than the sham-operated mice.
Compared to other treatments, the treatment with RNP pH resulted in significantly less damage, similar to the measurements of BUN and Cr.
We also investigated whether RNP pH could scavenge ROS, in particular superoxide, generated in the injured kidney. As shown in Fig. 4a and 4b, the generation of ROS in kidney was significantly inhibited by the treatment with RNP pH in comparison to other treatments. Additionally, we investigated whether RNPs can inhibit lipid peroxidation and generation of the inflammation cytokine. Compared with other treatments, treatment with RNP pH resulted in a significant reduction of thiobarbituric acid reactive substance (TBARS) levels, which serve as an index of lipid peroxidation in kidney, and the generation of inflammation cytokine in plasma, as can be seen in Fig. 4c and 4d , respectively. In particular, TBARS level of RNP pH treated group was statistically lower than that of other groups as shown in Fig. 4c . These results provide the reason of the high therapeutic efficiency of RNP pH .
Conformational changes of the nanoparticle in the injured kidney
To demonstrate the reason that RNP pH showed superior therapeutic effect on renal 6 ]. This long retention of nitroxide radicals in the kidney might be an important factor for the protection of renal function after IR, because excess ROS gradually continues to be generated after reperfusion [21] .
In addition, the administration of RNP pH evoked the triplet ESR signal in the IR kidney,
whereas RNP Non-pH did not show any change from the singlet spectra. This result strongly suggests the disintegration of RNP pH at the injured kidney lesion due to the lowered pH. Regardless of longest distribution of RNP Non-pH in ischemic renal lesion, the site-specific disintegration of RNP pH in the targeted organd would lead to the improved therapeutic effect on IR-AKI, as compared with RNP Non-pH .
The side effects of nitroxide radicals
Moreover, we investigated the side effects of TEMPO derivatives because TEMPO derivatives are known to show severe side effects; e.g., dose-related antihypertensive action accompanied by reflex tachycardia, increased skin temperature, and seizures [22] . In particular, hypotensive action would be a serious adverse event during the treatment and surgery. The mean arterial blood pressure was measured at 15 min after the intravenous administration of the drugs. As shown in Fig. 6 ,
4-amino-TEMPO and 4-hydroxy-TEMPO drastically decreases in arterial blood
pressure. In contrast, both RNPs inhibited the decrease in arterial blood pressure.
There were no significant differences between the control, RNP pH and RNP Non-pH groups.
Although the exact reason is still unknown, it is thought that the reduction of arterial blood pressure after administration of low-molecular-weight TEMPO derivatives is induced by an increase in endogenous nitric oxide (NO), resulting in vasodilatation in vivo [23, 24 ] . These results demonstrate that RNPs protect against blood pressure fluctuations because of the encapsulation of TEMPO moieties in hydrophobic core of RNP in the blood stream.
Discussion
Despite significant advances in medical treatments, AKI remains a major clinical problem associated with considerable morbidity and mortality, which has not decreased significantly over the last 50 years [25] . Although many promising drugs, in particular antioxidants, have been developed and shown to be of benefit in experimental models of AKI or renal IR injury, the results of recent clinical trials investigating these promising drugs have been largely negative. For example, the use of native SOD has faced a number of problems ranging from its rapid proteolytic degradation, immunogenicity in vivo to prooxidant and cytotoxic activities at higher concentrations [26] . Although low-molecular-weight TEMPO derivatives also show therapeutic effect on renal IR injuries as previous reported [27] , however, they are hard to utilize in clinic due to the side effects such as hypotensive action. Additionally, their preferential renal clearance inhibits long-term retainment of nitroxide radicals in injured renal lesion, resulting in lowered therapeutic effect.
Unlike the concept of existing drugs, the ESEPT can control the drug pharmacokinetics and the pharmaceutical activity due to the "on-off regulation" of nanoparticle in response to signal around target tissue area. We have to emphasize here that the nanoparticles possessing such signal switching characteristics tends to decrease their stability. Physical entrapment of low-molecular-weight drugs causes the leakage of the drug from the nanoparticle into the blood stream and would decrease in its therapeutic efficiency and cause severe side effects. Covalent conjugation of drug in hydrophobic segment of amphiphilic block copolymer, so called polymer drug, is one of the most important strategies to utilize "on-off" switching mechanism. As a result, the RNP pH has the excellent therapeutic effect and prevents side effect for renal IR-AKI model in mice due to the strategy of ESEPT. We have revealed the disintegration of nanoparticle in injured kidney using the ESR spectroscopy, which is provide the evidence of the real therapeutic effect using the environment-sensitive specific disintegration of nanoparticles in vivo. Given their enhanced ability to scavenge ROS and reduce side effect by RNP pH , the usage of RNP pH might be a promising therapeutic strategy toward other oxidative stress injuries, regardless of renal IR-AKI. Moreover, we believe that the strategy of ESEPT makes a contribution in clinical practice as a new type of nanomedicine.
Conclusion
This study demonstrates that the ESEPT strategy by pH-responsive RNP pH improves the therapeutic efficiency and suppresses the significant side effects, using
renal IR-AKI model in mice, due to the morphological change in nanoparticles within injured kidney area. This disintegration of RNP pH in injured kidney area was confirmed by ESR spectra, which is evidence of real therapeutic effect using the environmental-sensitive disintegration of nanoparticle worked in vivo. Furthermore, the side effect of nitroxide radicals was markedly suppressed due to the compartmentalization of nitroxide radicals in the core of RNP pH in untargeted area.
From these results, the RNP pH is promising as high performance nanomedicine toward oxidative stress injuries including renal IR-AKI. 
Methods:
Preparation of RNP pH by dialysis method 90 mg of MeO-PEG-b-PMNT were dissolved in 10 mL of DMF, and the polymer solution was transferred into a membrane tube (Spectra/Por, molecular-weight cutoff size: 3,500, Spectrum, USA) and then dialyzed for 24 h against 2 L of water, which was changed after 2, 5, 8 and 20 h. The RNP Non-pH was prepared from PEG-b-PMOT by the dialysis method, similar to RNP pH .
Preparation of non-pH-responsive nitroxide radical-containing-particle (RNP Non-pH )
Non-pH-responsive RNP Non-pH was prepared by a self-assembling amphiphilic block copolymer (PEG-b-PMOT) composed of the PEG segment and the PMS segment possessing TEMPO moieties as a side chain via ether linkage, as show in Fig. S1 . Briefly, after 200 mg (25 µmol) of the MeO-PEG-b-PCMS (Mn = 8,300) were weighed into a 10-mL flask, a DMF (1 mL) was added, then DMF (1 mL) involved 4-hydroxy-TEMPO (260 mg, 1.25 mmol) and sodium hydride (70.3 mg, 2.5 mmol) was added to the flask and stirred for 5 h at room temperature. The reacted polymer was filtrated and recovered by precipitation into 10 mL of cold 2-propanol (-15 °C) and centrifugation for 30 min at 5,000 rpm (4,500 g). In order to purify the obtained polymer, the precipitation-centrifugation cycle was repeated three times, followed by freeze-drying with benzene. The yield of the obtained PEG-b-PMOT copolymer was 70.0 % (184 mg).
Dynamic light scattering (DLS) experiments and X-band electron spin resonance (ESR) experiments as a function of pH
The light scattering intensities of the pH-sensitive RNP were measured as a function of pH using a light scattering spectrometer (Nano ZS, ZEN3600, Malvern Instruments, Ltd., UK) equipped with a He-Ne laser that produces vertically polarized incident beams at a detection angle of 173° at 25 °C. Briefly, 3.5 mg/mL of the RNP solution was prepared as stock solution A after the formation of the RNPs by the dialysis method. Britton-Robinson buffers (100 µL each) with various pH values, which were prepared from a stock solution containing 1M phosphoric acid, 1M boric acid and 1M acetic acid and by adjusting the pH value with NaOH, were added to stock solution A (400 µL). The mixtures with various pH values were transferred to the cells immediately, followed by DLS measurement. The ESR measurements were carried out under the following conditions: frequency, 9.4190 GHz; power, 8.00 mW; field, 333.8 ± 50 mT; sweep time, 2.0 min; modulation, 0.1 mT; time constant, 0.1 s.
Morphological studies
The kidneys were fixed in a 10 % neutral buffered formalin solution and embedded in paraffin for use in histopathological examination. Thick sections (4 µm) were cut, deparaffinized, hydrated and HE stained. The renal sections were examined in a blind fashion for tubular cell swelling, interstitial edema, and tubular dilatation in all treatments. Each kidney slide was examined and assigned according to the severity of changes using scores on a scale of none (-), mild (+), moderate (++), and severe (+++) damage. Table S1 Total dose of administration and TEMPO concentrations into all drugs
